A Multi-Center, Open-Label, Non-Randomized Phase II Study of Elsamitrucin (SPI 28090) In Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma View Homepage


Ontology type: schema:MedicalStudy     


Clinical Trial Info

YEARS

2004-2006

ABSTRACT

To determine the safety and efficacy of elsamitrucin in patients with relapsed or refractory non-Hodgkin's lymphoma (NHL). To determine if elsamitrucin is efficacious in a particular pathologic NHL subtype(s).

URL

https://clinicaltrials.gov/show/NCT00090090

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3142", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "description": "To determine the safety and efficacy of elsamitrucin in patients with relapsed or refractory non-Hodgkin's lymphoma (NHL). To determine if elsamitrucin is efficacious in a particular pathologic NHL subtype(s).", 
    "endDate": "2006-10-01T00:00:00Z", 
    "id": "sg:clinicaltrial.NCT00090090", 
    "keywords": [
      "multi-center", 
      "label", 
      "Phase II", 
      "patient", 
      "Non-Hodgkin's", 
      "safety", 
      "efficacy", 
      "lymphoma", 
      "non-Hodgkin 's lymphoma"
    ], 
    "name": "A Multi-Center, Open-Label, Non-Randomized Phase II Study of Elsamitrucin (SPI 28090) In Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma", 
    "sameAs": [
      "https://app.dimensions.ai/details/clinical_trial/NCT00090090"
    ], 
    "sdDataset": "clinical_trials", 
    "sdDatePublished": "2019-03-07T15:21", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "file:///pack/app/us_ct_data_00001.json", 
    "sponsor": [
      {
        "id": "https://www.grid.ac/institutes/grid.42505.36", 
        "type": "Organization"
      }, 
      {
        "id": "https://www.grid.ac/institutes/grid.432081.c", 
        "type": "Organization"
      }, 
      {
        "id": "https://www.grid.ac/institutes/grid.490448.5", 
        "type": "Organization"
      }
    ], 
    "startDate": "2004-04-01T00:00:00Z", 
    "subjectOf": [
      {
        "id": "sg:pub.10.1007/bf00210793", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025840223", 
          "https://doi.org/10.1007/bf00210793"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00210793", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025840223", 
          "https://doi.org/10.1007/bf00210793"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "type": "MedicalStudy", 
    "url": "https://clinicaltrials.gov/show/NCT00090090"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/clinicaltrial.NCT00090090'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/clinicaltrial.NCT00090090'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/clinicaltrial.NCT00090090'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/clinicaltrial.NCT00090090'


 

This table displays all metadata directly associated to this object as RDF triples.

36 TRIPLES      16 PREDICATES      27 URIs      18 LITERALS      1 BLANK NODES

Subject Predicate Object
1 sg:clinicaltrial.NCT00090090 schema:about anzsrc-for:3142
2 schema:description To determine the safety and efficacy of elsamitrucin in patients with relapsed or refractory non-Hodgkin's lymphoma (NHL). To determine if elsamitrucin is efficacious in a particular pathologic NHL subtype(s).
3 schema:endDate 2006-10-01T00:00:00Z
4 schema:keywords Non-Hodgkin's
5 Phase II
6 efficacy
7 label
8 lymphoma
9 multi-center
10 non-Hodgkin 's lymphoma
11 patient
12 safety
13 schema:name A Multi-Center, Open-Label, Non-Randomized Phase II Study of Elsamitrucin (SPI 28090) In Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
14 schema:sameAs https://app.dimensions.ai/details/clinical_trial/NCT00090090
15 schema:sdDatePublished 2019-03-07T15:21
16 schema:sdLicense https://scigraph.springernature.com/explorer/license/
17 schema:sdPublisher Ne8049bfa35bd4ae988387a9e3e235457
18 schema:sponsor https://www.grid.ac/institutes/grid.42505.36
19 https://www.grid.ac/institutes/grid.432081.c
20 https://www.grid.ac/institutes/grid.490448.5
21 schema:startDate 2004-04-01T00:00:00Z
22 schema:subjectOf sg:pub.10.1007/bf00210793
23 schema:url https://clinicaltrials.gov/show/NCT00090090
24 sgo:license sg:explorer/license/
25 sgo:sdDataset clinical_trials
26 rdf:type schema:MedicalStudy
27 Ne8049bfa35bd4ae988387a9e3e235457 schema:name Springer Nature - SN SciGraph project
28 rdf:type schema:Organization
29 anzsrc-for:3142 schema:inDefinedTermSet anzsrc-for:
30 rdf:type schema:DefinedTerm
31 sg:pub.10.1007/bf00210793 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025840223
32 https://doi.org/10.1007/bf00210793
33 rdf:type schema:CreativeWork
34 https://www.grid.ac/institutes/grid.42505.36 schema:Organization
35 https://www.grid.ac/institutes/grid.432081.c schema:Organization
36 https://www.grid.ac/institutes/grid.490448.5 schema:Organization
 




Preview window. Press ESC to close (or click here)


...